Targeting TRP ion channels for itch relief.
- Published in:
- Naunyn-Schmiedeberg's Archives of Pharmacology, 2015, v. 388, n. 4, p. 389, doi. 10.1007/s00210-014-1068-z
- By:
- Publication type:
- Article
Works in Naunyn-Schmiedeberg
Results: 7
1
2
TRPV4 as a therapeutic target for joint diseases.
- Published in:
- Naunyn-Schmiedeberg's Archives of Pharmacology, 2015, v. 388, n. 4, p. 437, doi. 10.1007/s00210-014-1078-x
- By:
- Publication type:
- Article
3
Targeting TRP channels for chronic cough: from bench to bedside.
- Published in:
- Naunyn-Schmiedeberg's Archives of Pharmacology, 2015, v. 388, n. 4, p. 401, doi. 10.1007/s00210-014-1082-1
- By:
- Publication type:
- Article
4
TRPA1 as a drug target-promise and challenges.
- Published in:
- Naunyn-Schmiedeberg's Archives of Pharmacology, 2015, v. 388, n. 4, p. 451, doi. 10.1007/s00210-015-1088-3
- By:
- Publication type:
- Article
5
Targeting TRP channels: beyond TRPV1.
- Published in:
- 2015
- By:
- Publication type:
- Editorial
6
AMG2850, a potent and selective TRPM8 antagonist, is not effective in rat models of inflammatory mechanical hypersensitivity and neuropathic tactile allodynia.
- Published in:
- Naunyn-Schmiedeberg's Archives of Pharmacology, 2015, v. 388, n. 4, p. 465, doi. 10.1007/s00210-015-1090-9
- By:
- Publication type:
- Article
7
TRPV4: physiological role and therapeutic potential in respiratory diseases.
- Published in:
- Naunyn-Schmiedeberg's Archives of Pharmacology, 2015, v. 388, n. 4, p. 421, doi. 10.1007/s00210-014-1058-1
- By:
- Publication type:
- Article